Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Bionanometer Industries Corp. was a biotechnology and nanotechnology company focused on the development and commercialization of health products using proprietary bionanometer technology. Formerly known as Xvariant, Inc., the company specialized in creating high-absorption nutritional supplements, including bionanometer-sized calcium and zinc, designed to improve bioavailability and therapeutic efficacy. Based in Shenzhen, China, the company targeted the domestic consumer health market before its securities were suspended by the SEC in 2013 due to a failure to file periodic reports. The company's primary business model involved applying nanotechnology to traditional mineral supplements to enhance their absorption in the human body.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Bionanometer Industries.